Latest Articles

Publication Date
GSK presents positive data for B7-H4-targeted ADC in gynecological cancers - GSK US

GSK presents positive data for B7-H4-targeted ADC in gynecological cancers GSK US

Published: April 12, 2026, 2:25 p.m.
GSK presents positive data for B7-H4-targeted ADC in gynecological cancers - GSK

GSK presents positive data for B7-H4-targeted ADC in gynecological cancers GSK

Published: April 12, 2026, 2:25 p.m.
Strong early data prompts GSK to plan five Phase 3 studies for gynecological cancer ADC - Endpoints News

Strong early data prompts GSK to plan five Phase 3 studies for gynecological cancer ADC Endpoints News

Published: April 12, 2026, 2:10 p.m.
Endometriosis is not just a gynecological disease - statnews.com

Endometriosis is not just a gynecological disease statnews.com

Published: March 26, 2026, 8:33 a.m.
Insilico Medicine and Aska enter gynecological collaboration - BioWorld MedTech

Insilico Medicine and Aska enter gynecological collaboration BioWorld MedTech

Published: March 25, 2026, 1 p.m.
1st gynecological surgery professorship expands access in Hawaiʻi - University of Hawaii System

1st gynecological surgery professorship expands access in Hawaiʻi University of Hawaii System

Published: March 20, 2026, 2:21 a.m.
The role of psychological care in the treatment of gynecological disorders in girls and young women ― an interdisciplinary perspective | Zborowska | Ginekologia Polska - Via Medica Journals

The role of psychological care in the treatment of gynecological disorders in girls and young women ― an interdisciplinary perspective | Zborowska | Ginekologia Polska Via Medica Journals

Published: March 10, 2026, 9:03 p.m.
Two uteruses: Living with a rare gynecological anomaly - vijesti.me

Two uteruses: Living with a rare gynecological anomaly vijesti.me

Published: March 3, 2026, 1:15 p.m.
Key Opinion Leader (KOL) Panel to Discuss Acrivon’s ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress - The Manila Times

Key Opinion Leader (KOL) Panel to Discuss Acrivon’s ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress The Manila Times

Published: Feb. 23, 2026, 1:16 p.m.
Key Opinion Leader (KOL) Panel to Discuss Acrivon’s ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress - Yahoo Finance

Key Opinion Leader (KOL) Panel to Discuss Acrivon’s ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress Yahoo Finance

Published: Feb. 23, 2026, 1 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!